Endobronchial ultrasound diagnostic yield for sarcoidosis in hilar vs. mediastinal lymph nodes
Authors:
- Naeman MahmoodNMNaeman Mahmood
- Steven WolfSWSteven Wolf
- Raj DashRDRaj Dash
- Xiaofei WangXWXiaofei Wang
- Scott L. ShoferSSScott L. Shofer
- Coral X. GiovacchiniCGCoral X. Giovacchini
- Michael DorryMDMichael Dorry
- Hakim Azfar AliHAHakim Azfar Ali
- Kamran MahmoodKMKamran Mahmood
- Momen M. WahidiMWMomen M. Wahidi
Open Access
- 1 September 2025
- journal article
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (9) , 6652-6660
Abstract
Background: Pulmonary sarcoidosis is diagnosed by endobronchial ultrasound-guided transbronchial needle aspirate (EBUS-TBNA) of hilar and mediastinal lymph nodes and the finding of non-caseating granulomatous inflammation. There are currently no guidelines about which lymph node stations to sample to optimize the diagnostic yield and it is unclear if there is a difference in the yield between hilar and mediastinal lymph node stations. The objective of this study was to assess the difference in the diagnostic yield of EBUS-TBNA for non-caseating granulomas between hilar and mediastinal lymph nodes. Methods: A retrospective study was performed and medical records were reviewed of all patients at a single institution who underwent EBUS-TBNA of thoracic lymph nodes to evaluate for sarcoidosis. Results: Two hundred twenty-five patients with suspicion of sarcoidosis underwent EBUS-TBNA for evaluation of hilar and mediastinal lymphadenopathy. The yield of EBUS-TBNA for non-caseating granulomas was 61.8% vs. 65.5%, P=0.46, for hilar and mediastinal lymph nodes, respectively. The sensitivity for sarcoidosis of EBUS-TBNA of hilar vs. mediastinal nodes was 66.9% [95% confidence interval (CI): 58.9–74.9%] vs. 71.1% (95% CI: 65.3–76.9%). The specificity for sarcoidosis of EBUS-TBNA of both hilar and mediastinal nodes was 100%. The diagnostic yield for non-caseating granulomas in patients who underwent hilar nodes biopsy only, mediastinal nodes biopsy only, and both hilar and mediastinal nodes biopsy was 71.4%, 67%, and 73.1%, respectively (P=0.63). In multivariable logistic regression analysis, the diagnostic yield of EBUS-TBNA was only associated with age [odds ratio (OR) 0.96; 95% CI: 0.94–0.98; PConclusions: The yield of EBUS-TBNA for non-caseating granulomas in patients with suspected sarcoidosis was similar between the hilar and mediastinal lymph nodes.Keywords
This publication has 29 references indexed in Scilit:
- Endobronchial ultrasound‐guided transbronchial needle aspiration for diagnosis of sarcoidosis in clinically unselected study populationsRespirology, 2014
- Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration vs Conventional Transbronchial Needle Aspiration in the Diagnosis of SarcoidosisChest, 2014
- Efficacy and safety of convex probe EBUS-TBNA in sarcoidosis: A systematic review and meta-analysisRespiratory Medicine, 2012
- A Randomized Controlled Trial of Standard vs Endobronchial Ultrasonography-Guided Transbronchial Needle Aspiration in Patients With Suspected SarcoidosisChest, 2009
- The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology, 2009
- Pulmonary SarcoidosisClinics in Chest Medicine, 2008
- High Accumulation of T Regulatory Cells Prevents the Activation of Immune Responses in Aged AnimalsThe Journal of Immunology, 2006
- The immune paradox of sarcoidosis and regulatory T cellsJournal of Experimental Medicine, 2006
- The Clinical Application and Cost Analysis of Fine-Needle Aspiration Biopsy in the Diagnosis of Mass Lesions in SarcoidosisChest, 2000
- Racial Differences in Sarcoidosis Incidence: A 5-Year Study in a Health Maintenance OrganizationAmerican Journal of Epidemiology, 1997